National PReCePT Programme: a before-and-after evaluation of the implementation of a national quality improvement programme to increase the uptake of magnesium sulfate in preterm deliveries

Author:

Edwards Hannah BORCID,Redaniel Maria TheresaORCID,Sillero-Rejon CarlosORCID,Margelyte RutaORCID,Peters Tim JORCID,Tilling KateORCID,Hollingworth WilliamORCID,McLeod HughORCID,Craggs PippaORCID,Hill ElizabethORCID,Redwood SabiORCID,Donovan JennyORCID,Treloar EmmaORCID,Wetz EllieORCID,Swinscoe Natasha,Ford Gary AORCID,Macleod JohnORCID,Luyt KarenORCID

Abstract

ObjectiveTo evaluate the effectiveness and cost-effectiveness of the National PReCePT Programme (NPP) in increasing use of magnesium sulfate (MgSO4) in preterm births.DesignBefore-and-after study.SettingMaternity units (N=137) within NHS England and the Academic Health Science Network (AHSN) in 2018.ParticipantsBabies born ≤30 weeks’ gestation admitted to neonatal units in England.InterventionsThe NPP was a quality improvement (QI) intervention including the PReCePT (Preventing Cerebral Palsy in Pre Term labour) QI toolkit and materials (preterm labour proforma, staff training presentations, parent leaflet, posters for the unit and learning log), regional AHSN-level support, and up to 90 hours funded backfill for a midwife ‘champion’ to lead implementation.Main outcome measuresMgSO4uptake post implementation was compared with pre-NPP implementation uptake. Implementation and lifetime costs were estimated.ResultsCompared with pre-implementation estimates, the average MgSO4uptake for babies born ≤30 weeks’ gestation, in 137 maternity units in England, increased by 6.3 percentage points (95% CI 2.6 to 10.0 percentage points) to 83.1% post implementation, accounting for unit size, maternal, baby and maternity unit factors, time trends, and AHSN. Further adjustment for early/late initiation of NPP activities increased the estimate to 9.5 percentage points (95% CI 4.3 to 14.7 percentage points). From a societal and lifetime perspective, the health gains and cost savings associated with the NPP effectiveness generated a net monetary benefit of £866 per preterm baby and the probability of the NPP being cost-effective was greater than 95%.ConclusionThis national QI programme was effective and cost-effective. National programmes delivered via coordinated regional clinical networks can accelerate uptake of evidence-based therapies in perinatal care.

Funder

National Institute for Health Research Applied Research Collaboration West

Health Foundation

AHSN Network

Publisher

BMJ

Subject

Obstetrics and Gynecology,General Medicine,Pediatrics, Perinatology and Child Health

Reference22 articles.

1. National Institute for Health and Care Excellence (NICE) guideline NG25 . Preterm labour and birth NG25. UK NICE; 2015.

2. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus;Doyle;Cochrane Database Syst Rev,2009

3. Economic evaluation and cost of interventions for cerebral palsy: a systematic review;Shih;Dev Med Child Neurol,2018

4. Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

5. NNAP . National neonatal audit programme (NNAP) annual report 2017. UK RCPCH; 2018.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3